Recent Advances in the Development of P-gp Inhibitors

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 4, 2009-05 ,pp. : 415-436

Bentham Science Publishers

Access to resources Recommend Favorite

EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P-gp substrates in vitro and in vivo

By              

Oncology Reports, Vol. 35, Iss. 2, 2016-01 ,pp. : 771-778

Spandidos Publications

Access to resources Recommend Favorite

Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression

By                    

Oncology Reports, Vol. 28, Iss. 3, 2012-01 ,pp. : 1077-1083

Spandidos Publications

Access to resources Recommend Favorite

A Dermatitis Control Program (DeCoP) for head and neck cancer patients receiving radiotherapy: a prospective phase II study

By Zenda Sadamoto  

International Journal of Clinical Oncology, Vol. 18, Iss. 2, 2013-04 ,pp. : 350-355

Springer Publishing Company

Access to resources Recommend Favorite

P-gp upregulation may be blocked by natural curcuminoids, a novel class of chemoresistance-preventing agent

By      

Molecular Medicine Reports, Vol. 7, Iss. 1, 2013-01 ,pp. : 115-121

Spandidos Publications

Access to resources Recommend Favorite